CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

The trial will be a collaborative effort between the company, the Norwegian Cancer Society, and Cancer Research UK.

The first clinical trial to test whether adults allergic to peanuts can be desensitized has shown great success with two ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Additionally, as previously announced, an oral presentation regarding Emi-Le will be given at the ESMO Breast Cancer 2025 ...

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

Mumbai: Sun Pharma and Israel-based Moebius Medical Limited have announced the publication of two articles in Osteoarthritis ...

GI Alliance has struck a strategic partnership with healthcare technology company Iterative Health. The partnership aims to expand access to clinical trials for GI patients, according to an April 23 ...

SAN DIEGO - Viking Therapeutics, Inc. (NASDAQ: VKTX) reported a wider-than-expected loss for the first quarter of 2025 as research and development expenses increased, but its stock edged up 1% ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which has ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging ...